MND Phase 1/2/3 Trial review what to expect. The Chemistry !, page-10

Hi Deebo,

What a great drug Dostarlimab is, of 18 patients in the trial each either it (endometrial cancer) disappeared or transitioned into remission.

It works by unmasking the cancer cells immune system to our own immune system.

It is made by GlaxoSmithKline and they seem intent on making their production and development costs back quickly. $ 32674 AUD per full treatment.

It also shows promise in stomach, prostate and pancreatic cancer.

A competitor to MPL no doubt, but to my line of thinking. MPL can be produced for the masses and be cost effective. All we need is a synergistic drug that has an excellent safety profile to match. They are out there. It's just a matter of someone picking up the ball.

Remember Suren Sehgal co discoverer of Rapamycin. He unfortunately acquired stage 4 metastatic colon cancer. He placed himself on Rapamycin for four years, defeating the odds and survived. To make sure it was the Rapamycin was the reason he was still alive, he discontinued the Rapamycin and succumbed to the cancer.

Cheers Kpax